Login to Your Account



Pharma: Other News To Note


Monday, September 30, 2013
• Mylan Inc., of Pittsburgh, and Agila Specialities Global Pte. Ltd., of Bangalore, India, have had conditions on Mylan’s proposed acquisition of Agila imposed by the Federal Trade Commission (FTC), which is requiring the firms to divest 11 generic injectable drugs prior to the acquisition.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription